article thumbnail

Surprise Medical Bills Could Be Reduced by COVID-19 Relief Package

The Pharma Data

Surprise Medical Bills Could Be Reduced by COVID-19 Relief Package. Patients will be protected from surprise bills related to emergency medical care if they are seen at an out-of-network facility or treated by an out-of-network clinician at an in-network hospital. Professional. TUESDAY, Dec.

article thumbnail

Researchers roll out a more accurate way to estimate genetic risks of disease

Broad Institute

Several people have already used the R package and reported that it generated a much better score than the scores from individual studies,” said Truong. Funding Support for this study was provided by the National Human Genome Research Institute; the National Heart, Lung, and Blood Institute; Massachusetts General Hospital, and other sources.

Disease 136
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

RECOVERY Trial Data Monitoring Committee Recommends Continuing Evaluation of REGN-COV2 in All Hospitalized Patients

The Pharma Data

Regeneron announced today an update from the independent data monitoring committee (DMC) for the United Kingdom-based RECOVERY trial evaluating REGN-COV2 in hospitalized patients with COVID-19.

article thumbnail

New England Journal of Medicine Publishes Positive Initial Regeneron Antibody Cocktail Results in Non-hospitalized Patients with COVID-19

The Pharma Data

(NASDAQ: REGN ) today announced that the New England Journal of Medicine (NEJM) has published initial clinical data from an ongoing seamless Phase 1/2/3 trial of the antibody cocktail casirivimab and imdevimab in non-hospitalized patients with COVID-19. “The investigational cocktail is now available to indicated high-risk U.S.

article thumbnail

REGN-COV2 Independent Data Monitoring Committee Recommends Holding Enrollment in Hospitalized Patients with High Oxygen Requirements and Continuing Enrollment in Patients with Low or No Oxygen Requirements

The Pharma Data

(NASDAQ: REGN) received today a recommendation from the independent data monitoring committee (IDMC) for the REGN-COV2 antibody cocktail treatment trials for COVID-19 that the current hospitalized patient trial be modified. About the REGN-COV2 Trial in Hospitalized Patients. Cohort 1A: patients not requiring oxygen.

article thumbnail

Red Cross Issues Call for More Blood Plasma to Treat COVID Patients

The Pharma Data

6, 2021 — The American Red Cross is urging COVID-19 survivors to donate blood plasma for hospital patients who need it to recover. The Red Cross is especially asking those who have recovered from COVID-19 to give blood because more donors are needed to help hospital patients. WEDNESDAY, Jan. Those who donate between Jan.

article thumbnail

Keeping tabs on Covid-19: Cell and gene clinical trials advance despite Covid-19…

The Pharma Data

CluePoints provides clinical studies with risk management support package during Covid-19. Patrick Hughes, Co-Founder and Chief Commercial Officer of CluePoints, said: “The response to our complimentary risk assessment package has been fantastic. NIH tests antibodies in Covid-19 clinical trial alongside Eli Lilly and AbCellera .